Anti-CD3 antibodies and uses thereof | Patent Number 11603405

US 11603405 B2

Application Number16418082

Publication NumberUS 20200048349 A1

Pendency3 years, 9 months, 28 days

Filled DateMay 21, 2019

Priority DateMay 24, 2018

Publication DateFeb 13, 2020

Expiration DateMay 23, 2038

Inventor/ApplicantsBradley Heidrich
Jill GILES-KOMAR
Francois Gaudet
Chichi Huang
Jennifer NEMETH-SEAY
Colleen Kane
Bradley HEIDRICH
Francois GAUDET
Jill Giles-Komar
Ronan McDaid
Jennifer Nemeth-Seay
Colleen KANE
Chichi HUANG
Ronan MCDAID

ExaminesTAYLOR, LIA ELAN

Art Unit1644

Technology Center1600

Assignments

Janssen Biotech Inc.

Current

Janssen Biotech Inc.Johnson & Johnson

Original

Law Firm

You must be logged in to view

Attorneys

Subscription-Only

View Concierge Program

See the invalidated claims, subscribe to our Concierge Program.

View Concierge Program

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.